A multi-district model for the management of disease-modifying treatments in multiple sclerosis

Author： Ford Helen L. Johnson Michael Fear Jon

ISSN： 1466-4100

Source： British Journal of Clinical Governance, Vol.7, Iss.4, 2002-12, pp. : 267-272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improving adherence to injectable disease-modifying drugs in multiple sclerosis

By Bayas Antonios

Expert Opinion on Drug Delivery, Vol. 10, Iss. 3, 2013-03 ,pp. : 285-287

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Alzheimer's Disease: Symptomatic and Disease-Modifying Approaches

Current Aging Science, Vol. 3, Iss. 1, 2010-02 ,pp. : 46-56

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Pharmacological Treatments for Chronic Pain: A Disease Management Context

By Dennis C. Turk

Disease Management & Health Outcomes, Vol. 13, Iss. 1, 2005-01 ,pp. : 19-30

Adis International

Access to resources Recommend Favorite

Smoking and multiple sclerosis susceptibility

By Hedström Anna Hillert Jan Olsson Tomas Alfredsson Lars

European Journal of Epidemiology, Vol. 28, Iss. 11, 2013-11 ,pp. : 867-874

Springer Publishing Company

Access to resources Recommend Favorite

Management of Relapsing-Remitting Multiple Sclerosis: Defining the Role of Subcutaneous Recombinant Interferon- -1a (Rebif)

By Lyseng-Williamson K.A. Plosker G.L.

Disease Management & Health Outcomes, Vol. 10, Iss. 5, 2002-01 ,pp. : 307-325

Adis International

Access to resources Recommend Favorite